TG rises on SPA for combination CLL therapy

TG Therapeutics Inc. (NASDAQ:TGTX) rose $2.65 (23%) to $14.37 after the company said it received an SPA from FDA

Read the full 197 word article

How to gain access

Continue reading with a
two-week free trial.